Theralase Technologies (Theralase Technologies) Price-to-Tangible-Book : 19.71 (As of May. 05, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Price-to-Tangible-Book?

As of today (2024-05-05), Theralase Technologies's share price is $0.11825. Theralase Technologies's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.01. Hence, Theralase Technologies's Price to Tangible Book Ratio of today is 19.71.

The historical rank and industry rank for Theralase Technologies's Price-to-Tangible-Book or its related term are showing as below:

TLTFF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.22 Med: 15 Max: 45.71
Current: 20

During the past 13 years, Theralase Technologies's highest Price to Tangible Book Ratio was 45.71. The lowest was 4.22. And the median was 15.00.

TLTFF's Price-to-Tangible-Book is ranked worse than
92.99% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 2.7 vs TLTFF: 20.00

A closely related ratio is called PB Ratio. As of today, Theralase Technologies's share price is $0.11825. Theralase Technologies's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.01. Hence, Theralase Technologies's P/B Ratio of today is 19.71.

Theralase Technologies Price-to-Tangible-Book Historical Data

The historical data trend for Theralase Technologies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Price-to-Tangible-Book Chart

Theralase Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.10

4.22

15.05

22.55

22.67

Theralase Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															14.68	22.55	33.45	33.08	22.67

Competitive Comparison of Theralase Technologies's Price-to-Tangible-Book

For the Medical Devices subindustry, Theralase Technologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Price-to-Tangible-Book falls into.

Theralase Technologies Price-to-Tangible-Book Calculation

Theralase Technologies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.11825	/	0.006
	=	19.71

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Theralase Technologies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies (Theralase Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

TLT:Canada

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.